About 85% of new medicines launched between 2012 and 2021 were available in the U.S., compared to 61% in Germany, 59% in the U.K. and 52% in France and Italy. Bluebird bio in 2021 said it was unwinding operations in Europe and withdrawing gene therapies for rare diseases, citing the challenges of “achieving appropriate value…
Category: Drug Prices & Regulations
Friday Links
- Reason (magazine) investigation: CDC used Facebook to silence Covid dissent.
- More than 1,000 nursing homes reached a 75% infection rate during the Covid pandemic.
- For: more off label uses of existing drugs.
- IRA bill is already affecting drug development – negatively.
- What it will cost to attend this year’s Super Bowl game: almost $9,000.
- The Manchin/Capito Trust Act would force Congress to do what it doesn’t want to do: Tackle our unfunded entitlement liabilities.
Thursday Links
- Half of all Medicare beneficiaries are now in Medicare Advantage plans.
- Gallup: 38% say they or a family member put off medical care because of costs – the highest number in 22 years.
- Cato: Black civil servants earned approximately 3.4 – 6.9 percentage points less because of the segregationist policies of Woodrow Wilson – the 20th century’s most prominent “progressive.”
- Mark Cuban’s online Cost Plus Drug Co. as 2 million customers. Cuban says the pharmacy could have saved his Dallas Mavericks basketball team $146,000. So why didn’t they?
Sneaky FDA Tricked Congress to Granting it the Power to Regulate the Practice of Medicine
The U.S. Food and Drug Administration (FDA) is tasked with ensuring the safety and effectiveness of drugs, and medical devices in addition to food and cosmetic safety. One thing the FDA is not responsible for is regulating the practice of medicine. The following is from an FDA Q & A website: